Cargando…

Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1

INTRODUCTION: To improve the standard treatment paradigm for glioblastoma (GBM), efforts have been made to explore the efficacy of epigenetic agents as chemosensitizers. Recent data suggest possible synergy between decitabine (DAC), a DNA hypomethylating agent, and temozolomide (TMZ) in GBM, but the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallitto, Matthew, Cheng He, Rossana, Inocencio, Julio F., Wang, Huaien, Zhang, Yizhou, Deikus, Gintaras, Wasserman, Isaac, Strahl, Maya, Smith, Melissa, Sebra, Robert, Yong, Raymund L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Laboratory Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256087/ https://www.ncbi.nlm.nih.gov/pubmed/32193690 http://dx.doi.org/10.1007/s11060-020-03461-4

Ejemplares similares

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

A novel 3D in vitro model of glioblastoma reveals resistance to temozolomide which was potentiated by hypoxia
por: Musah-Eroje, Ahmed, et al.
Publicado: (2019)

Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit
por: Castro, Michael, et al.
Publicado: (2021)

Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
por: Shinsato, Yoshinari, et al.
Publicado: (2013)

Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma
por: Pain, Margaret, et al.
Publicado: (2017)

Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma
por: Shao, Naiyuan, et al.
Publicado: (2018)

Reassembly of Nucleosomes at the MLH1 Promoter Initiates Resilencing Following Decitabine Exposure
por: Hesson, Luke B., et al.
Publicado: (2013)

Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines
por: Sun, Stella, et al.
Publicado: (2011)

Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma
por: Bikhezar, Fatima, et al.
Publicado: (2019)

The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment
por: Patties, Ina, et al.
Publicado: (2019)

Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
por: Park, Jae-Hyun, et al.
Publicado: (2015)

The proteomic response in glioblastoma in young patients
por: Deighton, Ruth F., et al.
Publicado: (2014)

Interactions among mitochondrial proteins altered in glioblastoma
por: Deighton, Ruth F., et al.
Publicado: (2014)

Microenvironment involved in FPR1 expression by human glioblastomas
por: Boer, J. C., et al.
Publicado: (2015)

The effects of antiepileptic drugs on the growth of glioblastoma cell lines
por: Lee, Ching-Yi, et al.
Publicado: (2016)

Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses
por: Conroy, Siobhan, et al.
Publicado: (2016)

The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma
por: Yue, Qi, et al.
Publicado: (2013)

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2016)

Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
por: Xia, Chang, et al.
Publicado: (2014)

miR-331-3p regulates expression of neuropilin-2 in glioblastoma
por: Epis, Michael R., et al.
Publicado: (2013)

Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells
por: Mizuguchi, Asako, et al.
Publicado: (2019)

Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma
por: Liu, Zhouzerui, et al.
Publicado: (2023)

Investigating the Potential of Lipids for Use as Biomarkers for Glioblastoma via an Untargeted Lipidomics Approach
por: Soylemez, Burcak, et al.
Publicado: (2023)

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2014)

Nerve Growth Factor Stimulates Glioblastoma Proliferation through Notch1 Receptor Signaling
por: Park, Jun Chul, et al.
Publicado: (2018)

Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence
por: Fontana, Andrea O., et al.
Publicado: (2017)

Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors
por: Hsu, Sanford P. C., et al.
Publicado: (2020)

Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
por: Mallawaaratchy, Duthika M., et al.
Publicado: (2016)

Synthesis of New Boron Derived Compounds; Anticancer, Antioxidant and Antimicrobial Effect in Vitro Glioblastoma Tumor Model
por: Koldemir-Gündüz, Meliha, et al.
Publicado: (2021)

Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM)
por: Amer, Rehab G., et al.
Publicado: (2022)

Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients
por: Aaberg-Jessen, Charlotte, et al.
Publicado: (2016)

Propranolol Inhibits the Proliferation of Human Glioblastoma Cell Lines through Notch1 and Hes1 Signaling System
por: Kim, Hyun Sik, et al.
Publicado: (2021)

Mapping and characterizing N6-methyladenine in eukaryotic genomes using single-molecule real-time sequencing
por: Zhu, Shijia, et al.
Publicado: (2018)

Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models
por: Keir, Stephen T., et al.
Publicado: (2018)

High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients
por: Hönikl, Lisa Stefanie, et al.
Publicado: (2020)

NETRIN-4 Protects Glioblastoma Cells FROM Temozolomide Induced Senescence
por: Li, Li, et al.
Publicado: (2013)

Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme
por: Han, Jing, et al.
Publicado: (2017)

A Novel Framework for Characterizing Genomic Haplotype Diversity in the Human Immunoglobulin Heavy Chain Locus
por: Rodriguez, Oscar L., et al.
Publicado: (2020)

Epigenetic Regulation in the Brain after Spinal Cord Injury : A Comparative Study
por: Park, Bit-Na-Ri, et al.
Publicado: (2013)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1ptv1ek3ocnfl1qft8lfpns2cv